Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Crescent Capital BDC, Inc. (CCAP:NASDAQ), powered by AI.
Crescent Capital BDC, Inc. is currently trading at $11.26. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Crescent Capital BDC, Inc. on Alpha Lenz.
View Crescent Capital BDC, Inc.'s valuation metrics on Alpha Lenz.
“Crescent Capital BDC, Inc.'s ROE is 4.8%. Explore profitability and growth together.”
Ask for details →Crescent Capital BDC, Inc. is a business development company that primarily focuses on the financing needs of middle-market companies in the United States. Its main function is to provide capital solutions to businesses that may not have ready access to traditional bank financing. Notably, Crescent Capital BDC, Inc. invests across a diverse range of industries, including healthcare, technology, manufacturing, and consumer goods, aiming to generate high income through interest and dividend earnings. As a key player in the private debt market, this company typically engages in making debt investments such as senior loans, subordinated debt, and other secured and unsecured debt securities. Crescent Capital BDC, Inc. helps to bolster business growth by providing essential financial support that enables companies to expand, innovate, and compete more effectively in their respective fields. Its activities significantly contribute to filling the capital gap observed in the post-global financial crisis landscape, reflecting its importance within the broader financial markets by fostering economic resilience and entrepreneurial development.
“Crescent Capital BDC, Inc.'s ROE is 4.8%. Explore profitability and growth together.”
Ask for details →Crescent Capital BDC, Inc. (ticker: CCAP) is a company listed on NASDAQ in the Financial Services sector (Asset Management).
The current price is $11.26 with a P/E ratio of -x and P/B of -x.
ROE is 4.77%. Annual revenue is $47M.